3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neoplasm Metastasis
4
Colorectal Neoplasms
2
Pancreatic Neoplasms
1
Neoplasms
1
HER2-Positive Primary Breast Cancer
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Adenocarcinoma
1
Interventions
pembrolizumab
4
Nivolumab
4
trametinib
2
relatlimab
2
larotrectinib
2
dabrafenib
2
binimetinib
2
Vemurafenib
2
Ipilimumab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
sapanisertib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
encorafenib
1
defactinib
1
copanlisib
1
cobimetinib
1
capivasertib
1
atezolizumab
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Melanoma
×
trastuzumab deruxtecan
×
Clear all
No trials found.